Skip to main content

Table 2 Funding of Clinical practice guidelines

From: Transparency of clinical practice guideline funding: a cross-sectional analysis of the German AWMF registry

2a Funding information provided by CPGs

Classification

 

S1

S2e

S2k

S3

Overall

  

Informal consensus

Systematic literature search

Structured consensus

Systematic literature search & Structured consensus

 

n

 

175

27

171

134

507

Funding statement (%)

No

113 (64.6)

2 (7.4)

20 (11.7)

0 (0.0)

135 (26.6)

Yes

24 (13.7)

24 (88.9)

142 (83.0)

125 (93.3)

315 (62.1)

Inconclusive

38 (21.7)

1 (3.7)

9 (5.3)

9 (6.7)

57 (11.2)

Funding source mentioned (%)

24 (13.7)

24 (88.9)

142 (83.0)

125 (93.3)

315 (62.1)

Funding type mentioned (%)

3 (1.7)

14 (51.9)

100 (58.5)

98 (73.1)

215 (42.4)

Statement of independence (%)

3 (1.7)

14 (51.9)

51 (29.8)

76 (56.7)

144 (28.4)

2b Funding sources for CPGs with available information

Classification

S1

S2e

S2k

S3

Overall

n

24

24

142

125

315

Scientific medical societies (%)

5 (20.8)

15 (62.5)

120 (84.5)

95 (76.0)

235 (74.6)

Contributions by authors (%)

22 (91.7)

14 (58.3)

68 (47.9)

66 (52.8)

170 (54.0)

Hospitals/Universities (%)

0 (0.0)

5 (20.8)

13 (9.2)

22 (17.6)

40 (12.7)

Independent agencies (%)

0 (0.0)

2 (8.3)

12 (8.5)

15 (12.0)

29 (9.2)

Guideline programs (%)

0 (0.0)

0 (0.0)

1 (0.7)

26 (20.8)

27 (8.6)

Self-regulatory bodies (%)

0 (0.0)

0 (0.0)

2 (1.4)

10 (8.0)

10 (3.2)

German Federal Government (%)

1 (4.2)

0 (0.0)

1 (0.7)

5 (4.0)

7 (2.2)

Pharmaceutical industry (%)

0 (0.0)

1 (4.2)

0 (0.0)

4 (3.2)

5 (1.6)

Other (%)

0 (0.0)

0 (0.0)

1 (0.7)

3 (2.4)

4 (1.3)

Insurances (%)

0 (0.0)

0 (0.0)

1 (0.7)

0 (0.0)

1 (0.3)

2c Funding types for CPGs with available information

Classification

S1

S2e

S2k

S3

Overall

n

3

14

100

98

215

Meeting costs (%)

1 (33.3)

9 (64.2)

94 (94.0)

92 (93.9)

196 (91.2)

Scientific costs (%)

1 (33.3)

8 (57.1)

17 (17.0)

69 (70.4)

95 (44.2)

Administrative costs (%)

2 (66.6)

5 (35.7)

8 (8.0)

49 (50.0)

64 (29.8)

Material costs (%)

0 (0.0)

3 (21.4)

16 (16.0)

38 (38.8)

57 (26.5)

Independent literature search and appraisal (%)

0 (0.0)

0 (0.0)

3 (3.0)

10 (10.2)

13 (6.0)

Other (%)

 

0 (0.0)

1 (7.1)

0 (0.0)

2 (2.0)

3 (1.4)

  1. 2 b Personal contributions by authors: honorary offices by guideline authors, donations by guideline authors; Independent agencies: patient organizations, funding associations of charitable foundations; Guideline programs: German Program for National Clinical Practice Guidelines (NVL Program), Guideline Program in Oncology (OL program); Self-regulatory bodies: e.g. National Association of Statutory Health Insurance Physicians; Insurances: statutory health insurance, private health insurance; Other: AWMF (S3), Conference surpluses (S3), Südwestmetall (S2k), Wilhelm-Woort-Price 2016 (S2k); multiple answers per CPG possible c Scientific costs: methodology (e.g. literature searches, critical appraisal), implementation; Administrative costs: secretaries, infrastructure ; Material costs: databases, publication, layout, purchasing literature; Meeting costs: Travel expenses for consensus conferences and working sessions, facility costs, moderators; Other: Course fees (S3), External designer (S3), Naive Panel (S2e); multiple answers per CPG possible. Only valid CPGs are shown.